Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of PDE-3 inhibitor, cilostazol, in
prevention and treatment of vascular dementia, in those with brain white matter lesions and
vascular risk factors.